市場調査レポート
商品コード
1386140
アデノウイルスワクチン市場レポート:2030年までの動向、予測、競合分析Adenovirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
アデノウイルスワクチン市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
世界のアデノウイルスワクチン市場は、2024年から2030年までのCAGRが7.5%で、2030年までに推定14億米ドルに達すると予測されています。この市場の主な促進要因は、がん遺伝子治療におけるワクチン接種ニーズの急増と製薬会社によるワクチン接種需要の急増です。アデノウイルスワクチンの世界市場の将来は、研究・学術、研究所、製薬・バイオテクノロジー市場でのビジネスチャンスにより有望視されています。
Lucintelの予測では、7型ワクチンは手頃な価格で即座に免疫を付与できることから、予測期間中に高い成長が見込まれます。
北米は、アデノウイルス感染の高い有病率と継続的な人口増加により、予測期間中に最も高い成長が見込まれます。
市場規模・推計:アデノウイルスワクチンの市場規模を金額(10億米ドル)で推計。
動向と予測分析:各種セグメント別、地域別の市場動向(2018年~2023年)と予測(2024年~2030年)。
セグメンテーション分析:アデノウイルスワクチンの市場規模をタイプ別、用途別、地域別に金額(10億米ドル)で推計。
地域別分析:アデノウイルスワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。
成長機会:アデノウイルスワクチン市場のタイプ、用途、地域別の成長機会分析。
戦略的分析:アデノウイルスワクチン市場のM&A、新製品開発、競合情勢など。
ポーターのファイブフォースモデルに基づく業界の競合強度分析。
The future of the global adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets. The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global adenovirus vaccine by type, application, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adenovirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adenovirus vaccine companies profiled in this report include-
Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.
North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.
Market Size Estimates: Adenovirus vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Adenovirus vaccine market size by type, application, and region in terms of value ($B).
Regional Analysis: Adenovirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adenovirus vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adenovirus vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global adenovirus vaccine market is expected to reach an estimated $1.4 billion by 2030.
Answer: The global adenovirus vaccine market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
Answer: The major drivers for this market are the rapidly increasing need for vaccinations in cancer gene therapies and surge in vaccination demand from pharmaceutical companies.
Answer: The future of the adenovirus vaccine market looks promising with opportunities in the research and academic, laboratories, and pharmaceutical & biotechnology markets.
Answer: Some of the key adenovirus vaccine companies are as follows:
Answer: Lucintel forecasts that type 7 vaccine is expected to witness higher growth over the forecast period due to its affordability and ability to instantly confer immunity.
Answer: North America is expected to witness highest growth over the forecast period due to due to the high prevalence of adenovirus infection and continuous population growth in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.